These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 3335027

  • 21. Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy.
    Klostergaard J, Leroux E, Siddik ZH, Khodadadian M, Tomasovic SP.
    Cancer Res; 1992 Oct 01; 52(19):5271-7. PubMed ID: 1394131
    [Abstract] [Full Text] [Related]

  • 22. Synergistic effects of combination therapy with human recombinant interleukin-2 and tumor necrosis factor in murine tumor models.
    Winkelhake JL, Stampfl S, Zimmerman RJ.
    Cancer Res; 1987 Aug 01; 47(15):3948-53. PubMed ID: 3496953
    [Abstract] [Full Text] [Related]

  • 23. 2-Deoxy-D-glucose enhances sensitivity of human histiocytic lymphoma U937 cells to apoptosis induced by tumor necrosis factor.
    Halicka HD, Ardelt B, Li X, Melamed MM, Darzynkiewicz Z.
    Cancer Res; 1995 Jan 15; 55(2):444-9. PubMed ID: 7812976
    [Abstract] [Full Text] [Related]

  • 24. Combined effect of 5-fluorouracil and recombinant tumor necrosis factor against human gastric carcinoma cell lines.
    Li Y, Ito S, Cheng W, Ishii Y.
    Anticancer Res; 1996 Jan 15; 16(4A):1771-4. PubMed ID: 8712699
    [Abstract] [Full Text] [Related]

  • 25. Failure to enhance the in vivo killing of human ovarian carcinoma by sequential treatment with dequalinium chloride and tumor necrosis factor.
    Manetta A, Emma D, Gamboa G, Liao S, Berman M, DiSaia P.
    Gynecol Oncol; 1993 Jul 15; 50(1):38-44. PubMed ID: 8349163
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Mechanisms by which chemotherapeutic agents augment the antitumor effects of tumor necrosis factor: involvement of the pattern shift of cytokines from Th2 to Th1 in tumor lesions.
    Inagawa H, Nishizawa T, Honda T, Nakamoto T, Takagi K, Soma G.
    Anticancer Res; 1998 Jul 15; 18(5D):3957-64. PubMed ID: 9854510
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Anti-tumor effect and mechanism of action of the tumor necrosis factor (TNF)].
    Niitsu Y, Watanabe N, Sone H, Neda H, Yamauchi N, Ohtsuka Y, Umeno H.
    Gan To Kagaku Ryoho; 1987 Jun 15; 14(6 Pt 2):2089-97. PubMed ID: 3038032
    [Abstract] [Full Text] [Related]

  • 34. Anti-tumor activity of recombinant tumor necrosis factor on mouse fibrosarcoma in vivo and in vitro.
    Tomazic VJ, Farha M, Loftus A, Elias EG.
    J Immunol; 1988 Jun 01; 140(11):4056-61. PubMed ID: 3372997
    [Abstract] [Full Text] [Related]

  • 35. Overexpression of manganese-containing superoxide dismutase confers resistance to the cytotoxicity of tumor necrosis factor alpha and/or hyperthermia.
    Li JJ, Oberley LW.
    Cancer Res; 1997 May 15; 57(10):1991-8. PubMed ID: 9157996
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Role of tumor necrosis factor alpha in hyperthermia-induced apoptosis of human leukemia cells.
    Katschinski DM, Robins HI, Schad M, Frede S, Fandrey J.
    Cancer Res; 1999 Jul 15; 59(14):3404-10. PubMed ID: 10416602
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.